BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Castaño-Rodríguez N, Mitchell HM, Kaakoush NO. NAFLD, Helicobacter species and the intestinal microbiome. Best Pract Res Clin Gastroenterol 2017;31:657-68. [PMID: 29566909 DOI: 10.1016/j.bpg.2017.09.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Yu J, Sun H, Yang Y, Yan Y. Sesamolin Alleviates Nonalcoholic Fatty Liver Disease through Modulating Gut Microbiota and Metabolites in High-Fat and High-Fructose Diet-Fed Mice. IJMS 2022;23:13853. [DOI: 10.3390/ijms232213853] [Reference Citation Analysis]
2 Lupu A, Miron IC, Cianga AL, Cernomaz AT, Lupu VV, Gavrilovici C, Stârcea IM, Tarca E, Ghica DC, Fotea S. The Prevalence of Liver Cytolysis in Children with Helicobacter pylori Infection. Children (Basel) 2022;9:1498. [PMID: 36291434 DOI: 10.3390/children9101498] [Reference Citation Analysis]
3 Kountouras J, Papaefthymiou A, Polyzos SA, Liatsos C, Tzitiridou-chatzopoulou M, Chatzopoulos D, Vardaka E, Gialambrinou D, Kotronis G, Doulberis M. Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease. Metabolism 2022. [DOI: 10.1016/j.metabol.2022.155276] [Reference Citation Analysis]
4 Sun D, Zuo C, Huang W, Wang J, Zhang Z. Triclosan targeting of gut microbiome ameliorates hepatic steatosis in high fat diet-fed mice. J Antibiot (Tokyo) 2022. [PMID: 35440769 DOI: 10.1038/s41429-022-00522-w] [Reference Citation Analysis]
5 Ju Z, Shen L, Zhou M, Luo J, Yu Z, Qu C, Lei R, Lei M, Huang R. Helicobacter pylori and Alzheimer's Disease-Related Metabolic Dysfunction: Activation of TLR4/Myd88 Inflammation Pathway from p53 Perspective and a Case Study of Low-Dose Radiation Intervention. ACS Chem Neurosci 2022;13:1065-81. [PMID: 35312296 DOI: 10.1021/acschemneuro.2c00082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Maeda T, Zai H, Fukui Y, Kato Y, Kumade E, Watanabe T, Furusyo N, Nakajima H, Arai K, Ishii Y, Tateda K, Urita Y. Impact of Helicobacter pylori infection on fluid duodenal microbial community structure and microbial metabolic pathways. BMC Microbiol 2022;22:27. [PMID: 35033024 DOI: 10.1186/s12866-022-02437-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Kozaczek M, Kong B, Bottje W, Hakkak R. Hepatic Proteomics Analysis of Nonalcoholic Fatty Liver Disease Obese Rat Model After Short- and Long-Term Soy Protein Isolate Feeding. J Med Food 2021. [PMID: 34883038 DOI: 10.1089/jmf.2021.0088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang J, Li Y, Xiao G, Li Y, Xie H, Chen Y. Fructooligosaccharides enhance the therapeutic effect of xiao-zhi-fang on non-alcoholic fatty liver disease via regulating intestinal flora. Liver Research 2021;5:217-23. [DOI: 10.1016/j.livres.2021.06.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Isayev HB, Ibrahimov MR, Salimov TH. Dependence of the state of the large intestine parietal microflora on the activity of Helicobacter pylori associated chronic gastritis. jour 2021;20:44-48. [DOI: 10.52420/2071-5943-2021-20-3-44-48] [Reference Citation Analysis]
10 Gebru YA, Gupta H, Kim HS, Eom JA, Kwon GH, Park E, Jeong JJ, Won SM, Sharma SP, Ganesan R, Kim DJ, Suk KT. T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease. Int J Mol Sci 2021;22:12190. [PMID: 34830072 DOI: 10.3390/ijms222212190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
11 Wang X, Liu D, Wang Z, Cai C, Jiang H, Yu G. Porphyran-derived oligosaccharides alleviate NAFLD and related cecal microbiota dysbiosis in mice. FASEB J 2021;35:e21458. [PMID: 33948987 DOI: 10.1096/fj.202000763RRR] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 Wang J, Dong F, Su H, Zhu L, Shao S, Wu J, Liu H. H. pylori is related to NAFLD but only in female: A Cross-sectional Study. Int J Med Sci 2021;18:2303-11. [PMID: 33967606 DOI: 10.7150/ijms.50748] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Kozaczek M, Bottje W, Kong B, Albataineh D, Hakkak R. A Comparison of Short- and Long-Term Soy Protein Isolate Intake and Its Ability to Reduce Liver Steatosis in Obese Zucker Rats Through Modifications of Genes Involved in Inflammation and Lipid Transport. J Med Food 2021. [PMID: 33751907 DOI: 10.1089/jmf.2020.0180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Gong MJ, Zhu CY, Zou ZJ, Han B, Huang P. Therapeutic potential of puerarin against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis determined by combination of 1H NMR spectroscopy-based metabonomics and 16S rRNA gene sequencing. J Pharm Biomed Anal 2021;197:113964. [PMID: 33601157 DOI: 10.1016/j.jpba.2021.113964] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
15 李 婷. The Mechanism of Nonalcoholic Fatty Liver Disease Induced by Helicobacter pylori Infection. ACM 2021;11:3865-3869. [DOI: 10.12677/acm.2021.119566] [Reference Citation Analysis]
16 Kozaczek M, Bottje W, Kong B, Dridi S, Albataineh D, Lassiter K, Hakkak R. Long-Term Soy Protein Isolate Consumption Reduces Liver Steatosis Through Changes in Global Transcriptomics in Obese Zucker Rats. Front Nutr 2020;7:607970. [PMID: 33363197 DOI: 10.3389/fnut.2020.607970] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Yang Z, Xia Q, Lu D, Yue H, Zhang J, Li Y, Zhang B, Li X, Cao M. Human mesenchymal stem cells treatment improved hepatic lesions and reversed gut microbiome disorder in non-alcoholic steatohepatitis. Aging (Albany NY) 2020;12:21660-73. [PMID: 33168782 DOI: 10.18632/aging.103962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Shao M, Ye Z, Qin Y, Wu T. Abnormal metabolic processes involved in the pathogenesis of non-alcoholic fatty liver disease (Review). Exp Ther Med 2020;20:26. [PMID: 32934691 DOI: 10.3892/etm.2020.9154] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
19 Zhou QH, Wu FT, Pang LT, Zhang TB, Chen Z. Role of γδT cells in liver diseases and its relationship with intestinal microbiota. World J Gastroenterol 2020; 26(20): 2559-2569 [PMID: 32523311 DOI: 10.3748/wjg.v26.i20.2559] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
20 Xu MY, Ma JH, Du J, Yin J, Liu L, Cui F, Lu QB. Nonalcoholic Fatty Liver Disease Is Associated with Helicobacter pylori Infection in North Urban Chinese: A Retrospective Study. Gastroenterol Res Pract 2020;2020:9797841. [PMID: 32411211 DOI: 10.1155/2020/9797841] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
21 Rein-Fischboeck L, Haberl EM, Pohl R, Feder S, Liebisch G, Krautbauer S, Buechler C. Variations in hepatic lipid species of age-matched male mice fed a methionine-choline-deficient diet and housed in different animal facilities. Lipids Health Dis 2019;18:172. [PMID: 31521175 DOI: 10.1186/s12944-019-1114-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
22 Mantovani A, Turino T, Altomari A, Lonardo A, Zoppini G, Valenti L, Tilg H, Byrne CD, Targher G. Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis. Metabolism 2019;96:56-65. [DOI: 10.1016/j.metabol.2019.04.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
23 Nobs SP, Tuganbaev T, Elinav E. Microbiome diurnal rhythmicity and its impact on host physiology and disease risk. EMBO Rep 2019;20:e47129. [PMID: 30877136 DOI: 10.15252/embr.201847129] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 14.3] [Reference Citation Analysis]
24 Covasa M, Stephens RW, Toderean R, Cobuz C. Intestinal Sensing by Gut Microbiota: Targeting Gut Peptides. Front Endocrinol (Lausanne) 2019;10:82. [PMID: 30837951 DOI: 10.3389/fendo.2019.00082] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 16.0] [Reference Citation Analysis]
25 Wojciech Łapiński T. The Importance of H. pylori Infection in Liver Diseases. Helicobacter pylori [Working Title] 2018. [DOI: 10.5772/intechopen.79969] [Reference Citation Analysis]
26 Yao M, Zheng W, Wang L, Fang M, Dong Z, Yao D. Novel Mechanism of Nonalcoholic Lipid Accumulation Promoting Malignant Transformation of Hepatocytes. Neoplasm 2018. [DOI: 10.5772/intechopen.77400] [Reference Citation Analysis]
27 Yu Z, Song G, Liu J, Wang J, Zhang P, Chen K. Beneficial effects of extracellular polysaccharide from Rhizopus nigricans on the intestinal immunity of colorectal cancer mice. International Journal of Biological Macromolecules 2018;115:718-26. [DOI: 10.1016/j.ijbiomac.2018.04.128] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]